Back
Halozyme Therapeutics Stock Predictions

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
57
HALO
Halozyme Therapeutics
Last Price:
$56.46
Seasonality Move:
-2.44%
7 Day Trial
ALL ACCESS PASS
$
7
Halozyme Therapeutics Stock Forecast
-
Over the next 52 weeks, Halozyme Therapeutics has on average historically risen by 30.2% based on the past 21 years of stock performance.
-
Halozyme Therapeutics has risen higher in 14 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Halozyme Therapeutics Stock Undervalued?The current Halozyme Therapeutics [HALO] share price is $56.45. The Score for HALO is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
HALO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Halozyme Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Halozyme Therapeutics has on average historically risen by 30.2% based on the past 21 years of stock performance.
Halozyme Therapeutics Stock Rating
Buy
57
Halozyme Therapeutics (HALO)
is a Buy
Is Halozyme Therapeutics overpriced?
-
Halozyme Therapeutics has risen higher in 14 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Halozyme Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
halozyme.com
52-Week Data
52-Week High:
70.51
52-Week Low:
42.01
Prediction Charts
Market Cap:
7B
Price in USD:
56.45
Volume:
1.1M
Beta:
1.41
Technical Analysis
SMA50:
55.13
SMA100:
57.94
SMA200:
55.39
52-Wk Change:
3.96%
Stock Predictions
-
Is Halozyme Therapeutics stock public?Yes, Halozyme Therapeutics is a publicly traded company.
-
What is the Halozyme Therapeutics stock quote today?The Halozyme Therapeutics stock price is 56.45 USD today.
-
How to buy Halozyme Therapeutics stock online?You can buy Halozyme Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Jun-30 | 52.66 | 52.02 | 53.44 | 51.06 |
Jul-1 | 51.78 | 52.92 | 53.31 | 51.78 |
Jul-2 | 52.92 | 53.84 | 54.25 | 52.72 |
Jul-3 | 53.54 | 54.00 | 54.17 | 53.33 |
Jul-7 | 53.82 | 54.22 | 54.34 | 53.65 |
Jul-8 | 54.17 | 55.80 | 56.21 | 54.15 |
Jul-9 | 56.66 | 56.58 | 57.19 | 56.06 |
Jul-10 | 56.39 | 57.63 | 57.97 | 56.19 |
Jul-11 | 57.37 | 57.15 | 57.86 | 56.79 |
Jul-14 | 57.24 | 57.65 | 58.14 | 57.16 |
Jul-15 | 57.71 | 56.60 | 57.82 | 56.56 |
Jul-16 | 57.09 | 58.01 | 58.45 | 57.01 |
Jul-17 | 58.10 | 57.81 | 58.56 | 57.57 |
Jul-18 | 57.85 | 56.45 | 57.85 | 56.38 |
Halozyme Therapeutics Earnings
Halozyme Therapeutics Earnings Report: Per Share Halozyme Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Halozyme Therapeutics Forecast Revenue Growth
Halozyme Therapeutics Stock Analysis: Historical quarterly revenues per share for Halozyme Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.44 per share, an increase next quarter of $0.06 per share, an increase this year of $1.27 per share, and an increase next year of $1.48 per share.
* Halozyme Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.